ICCM · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus · Market Cap: $0.0B · 66 employees
164
SEC Filings
$3.13
Close 2026-08-04
66
Employees
Business Summary
IceCure Medical Ltd. is a medical device company focused on cryoablation technology for interventional oncology. Its primary product, the ProSense system, uses liquid nitrogen-based cryoablation to treat tumors, and has received FDA De Novo authorization for early-stage, biologically low-risk breast cancer. The company is transitioning to its next-generation XSense system, which has received FDA 510(k) clearance. Future development includes the MSense system targeting breast, kidney, lung, liver, and bone cancers.
Look up ICCM using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on ICCM, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/ICCM (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.